W. Spicer

发表

Investigation of an Apparent Cluster of Klebsiella pneumoniae Bacteremias Using Random Amplified Polymorphic DNA Analysis

J. Hurley, G. Harrington, E. G. Russell, 1996, Infection Control & Hospital Epidemiology.

Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery.

D. Spelman, J. Smith, D. Esmore, 2000, The Australian and New Zealand journal of surgery.

Drug Use Evaluation ofVancomycin Based on Hospital Policy and Published Guidelines

H. Krum, C. Rayner, D. Spelman, 1998 .

Minimisation of aminoglycoside toxicity in patients with cystic fibrosis.

P. Wood, A. Mclean, T. Williams, 1996, Thorax.

Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing

P. Wood, A. Mclean, W. Spicer, 1996, Antimicrobial agents and chemotherapy.

Antibiotic prophylaxis for coronary bypass grafting. Comparison of a five-day and a two-day course.

F. Rosenfeldt, W. Spicer, G. Stirling, 1983, The Journal of thoracic and cardiovascular surgery.

Three strategies in the control of staphylococci including methicillin-resistant Staphylococcus aureus.

W. Spicer, W.John Spicer, 1984, The Journal of hospital infection.

Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes

J. McNeil, P. Brooks, F. Bochner, 1989, The Medical journal of Australia.

CD4 Lymphocyte Numbers after Splenectomy in Patients Infected with the Human Immunodeficiency virus

C. Fairley, S. Crowe, D. Spelman, 1994, International journal of STD & AIDS.

Metronidazole pharmacokinetics in patients with acute renal failure.

Á. Somogyi, A. Mclean, W. Spicer, 1984, The Journal of antimicrobial chemotherapy.

Aminoglycoside dosing: one, two or three times a day?

A. Mclean, W. Spicer, N. Christophidis, 1996, The Medical journal of Australia.

Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens

B. Balkau, M. Deighton, W. Spicer, 1988, Epidemiology and Infection.

Changes in MIC Alter Responses of Pseudomonas aeruginosa to Tobramycin Exposure

P. Wood, A. Mclean, L. Liolios, 1998, Antimicrobial Agents and Chemotherapy.

Clinical Microbiology and Infectious Diseases

W. Spicer, R. Britton, I. Lamb, 2007 .

Disposition and removal of metronidazole in patients undergoing haemodialysis

Á. Somogyi, A. Mclean, W. Spicer, 2004, European Journal of Clinical Pharmacology.

Current clinical applications and dose regimens of metronidazole and related nitroimidazoles *

A. Mclean, W. Spicer, Lisa L Loannides‐Demos, 1984, The Medical journal of Australia.

Tuberculous pancreatic abscess in an HIV antibody-negative patient: case report and review.

M. Hellard, D. Spelman, A. Jenney, 1998, Scandinavian journal of infectious diseases.

Aminoglycoside antibiotic agents: a review

M. McDonald, D. Spelman, W. Spicer, 1989, The Medical journal of Australia.

CASE REPORTS: INDIGENOUS INVASIVE AMOEBIASIS IN AUSTRALIA

D. Spelman, W. Spicer, A. Weinmann, 1992 .

Indigenous invasive amoebiasis in Australia.

D. Spelman, W. Spicer, A. Weinmann, 1992, Australian and New Zealand Journal of Surgery.

Assessment of head-space gas-liquid chromatography for the rapid detection of growth in blood cultures.

W. Spicer, M. Huysmans, 1985, Journal of chromatography.

Effect of collection tube on measured gentamicin and vancomycin concentrations.

H. Krum, C. Rayner, W. Spicer, 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Bactericidal effect of gentamicin peak concentration provides a rationale for administration of bolus doses.

A. Mclean, W. Spicer, E. B. Bastone, 1993, The Journal of antimicrobial chemotherapy.

Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing

A. Mclean, W. Spicer, E. B. Bastone, 1993, Antimicrobial Agents and Chemotherapy.

Kill Kinetics andRegrowth Patterns ofEschenichia coli Exposed toGentamicin Concentration-Time Profiles Simulating InVivoBolusandInfusion Dosing

Shu Chuen Li, W. Spicer, Allan J. McLEANl, 1993 .

The usage and costs of health services for HIV infection in Australia

J. Carlin, J. Kaldor, D. Evans, 1995, AIDS.

Laboratory Diagnosis of Bacteremia by Head‐Space Gas‐Liquid Chromatography

N. Hayward, W. Spicer, 1983, Pathology.

Bactericidal effect of gentamicin trough concentration provides a rationale for administration of bolus doses and maintenance of trough levels.

A. Mclean, W. Spicer, E. B. Bastone, 1994, The Journal of antimicrobial chemotherapy.

Dosage adjustment and clinical outcomes of long-term use of high-dose tobramycin in adult cystic fibrosis patients.

A. Mclean, D. Spelman, G. Bowes, 1991, The Journal of antimicrobial chemotherapy.

Endocarditis following skin procedures.

D. Spelman, W. Spicer, A. Weinmann, 1993, The Journal of infection.

Cephalosporin clinical concentration-time profile modelling and in-vitro bactericidal effects on Escherichia coli.

A. Mclean, L. Liolios, W. Spicer, 1999, The Journal of antimicrobial chemotherapy.

Prospective audit of an aminoglycoside consultative service in a general hospital.

A. Mclean, D. Spelman, W. Spicer, 1992, The Medical journal of Australia.

Concentration dependence of gentamicin post-bolus peak effect on Escherichia coli kill kinetics.

A. Mclean, L. Liolios, W. Spicer, 1995, The Journal of antimicrobial chemotherapy.

A prospective study of the effects of oral probenecid on the pharmacokinetics of intravenous ticarcillin in patients with cystic fibrosis.

A. Mclean, D. Spelman, G. Bowes, 1992, The Journal of antimicrobial chemotherapy.

Clinical bacteriology,mycology and Parasitology:an illustrated colour text

W. Spicer, 2000 .

CD4 lymphocyte counts in HIV/AIDS patients with intercurrent illness.

C. Fairley, D. Spelman, I. Woolley, 1996, AIDS.